Scholars Central

Conference abstractPublished 22 Sep 2016

The NeXtStep in SPR based fragment screening

Authors: Eric L Reese

SensiQ Technologies Inc., USA

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

SensiQâÂ?Â?s patented gradient injection methods provide KDâÂ?Â?s from single injections, allowing SensiQ instruments to eliminate secondary screens such as one competitorâÂ?Â?s âÂ?Â?Affinity ScreenâÂ?. No other SPR providers have gradient injection technology. SensiQ Pioneer FE customers have demonstrated that a combination of excellent sensitivity, OneStepÃ?® gradient injections and the integrated Active Selection software provides superior results over other SPR suppliers. Now SensiQ has developed a new binding competition assay method for rapidly screening fragments, NeXtStep. Like OneStepÃ?®, NeXtStep enables full kinetic analysis in single competition injection and competition is clearly seen as a lack of binding in the presence of the competitor. Taken together, OneStepÃ?® and NeXtStep enable straight forward fragment screening workflow optimization and thus a faster drug discovery process.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Biosensors & Bioelectronics.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalBiosensors & Bioelectronics
  • BylineArticles whose byline prints “Eric L Reese”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels